Endocrine pharma Flashcards

1
Q

What are insulin dependent T2DM drugs?
Independent?
Mechanisms?

A

Insulin dependent

  • Sulphonylureas, incretin mimetics, glinides, DPP4 inhibitors (increase secretion of insulin)
  • metformin, TZDs (reduce insulin resistance)

Insulin independent

  • a-glucosidase inhibitors (slow glucose absorption from GI tract)
  • SGLT2 inhibitors (enhance glucose excretion by kidney)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Process of insulin secretion in pancreatic B cell? (6)

A
  • Elevation of blood glucose concentration
  • Increased diffusion of glutamate into the -cell by facilitated transport (GLUT2)
  • Phosphorylation of glucose by glucokinase
  • Glycolysis of glucose-6-phosphate in mitochondria yielding ATP
  • Increased ATP/ADP ratio within cell closes ATP-sensitive K+ channels causing membrane depolarization
  • Opening of voltage-activated Ca2+ channels increases intracellular Ca2+ that triggers insulin secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mechanism of sulphonylureas?

A
  • Bind to SUR1 receptors on KATP channel, closing the channel
  • Causes depolarisation of B cell + insulin release

REMEMBER: insulin dependent but NOT glucose dependent!!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are sulphonylureas classed as?

A

Insulin secretogogues - they cause pancreatic B cell insulin secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Examples of sulphonylureas?

What is their effect?

A
  • Tolbutamide
  • Gliclazide
  • Glipizide

Effect = decrease fasting and post-prandial blood glucose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do sulphonylureas close the K+ channel?

A

Displace the binding of ADP-Mg from the SUR1 subunit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Duration of action of sulphonylureas?

A
  • short-acting = tolbutamide

* long-acting = glibenclamide, gliclazide, glipizide (more potent than tolbutamide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Disadvantages of sulphonylureas? (2)

A
  • Hypoglycaemia (because they act independent of glucose!) - especially with long-acting agents, elderly, chronic kidney disease
  • Weight gain = appetite increased, urinary loss of glucose decreased
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What groups should sulphonylureas be avoided in?

A
  • CKD
  • Elderly
  • Pregnancy
  • Breast-feeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Difference between glinides and sulphonylureas?

A
  • Act similarly to the sulfonylureas, but their action is augmented by glycaemia
  • Lack the sulphonyl urea moiety, – bind to SUR1 (at a distinct benzamido site) to close the KATP channel and trigger insulin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples of glinides?

A

repaglinide + nateglinide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanism glinides?

Benefit over sulphonylureas? (2)

A

Have rapid onset of action!! Promote insulin secretion in response to meals

  • less likely to cause hypo
  • safer than SUs in CKD because mainly hepatic metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs can glinides be used in conjunction with?

Contraindications? (3)

A
  • Metformin + TZDs

Contraindications = severe hepatic impairment, pregnancy and breast feeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is the insulin response to oral glucose greater than the response to IV glucose?
Explain? (6)

A

Incretin effect

  • GLP-1 and GIP released from L cells in ileum and K cells in duodenum following food ingestion
  • Enter portal blood
  • GLP-1 = enhances insulin release + decreases glucagon release
  • GIP = enhances insulin release
  • Results in enhanced glucose uptake + decreased glucose production
  • DECREASED blood glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

DPP4-inhibitors also known as?

Mechanism of action?

A

Gliptins

* Competitively inhibit DPP-4 which normally breaks down GLP-1 and GIP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Example of gliptin?
Adminstration?
Benefits? (2)
Side effect?

A

Sitagliptin

  • Administered once daily orally
  • no hypoglycaemia + weight neutral
  • Side effect = nausea
17
Q

What are incretin analogues? Examples?

Mechanism of action?

A

Peptides that mimic the action of GLP-1 but are FAR longer lasting due to resistance to breakdown by DPP-4!!
* Extenatide + liraglutide

Mechanism = bind as agonists to GPCR GLP-1 receptors that increase intracellular cAMP concentration in pancreatic β-cells to stimulate insulin expression and release

18
Q

Effects of incretin analogues?

A
  • suppress glucagon secretion
  • slow gastric emptying
  • decrease appetite (hypothalamic action)
  • modest weight loss
  • Reduce hepatic fat accumulation
19
Q

Administration incretin analogues?
Benefit?
Side effects? (2)

A

Subcutaneously
* does not cause hypo

Side effects = nausea + pancreatitis (very rare)

20
Q

What is a-glucosidase? a-glucosidase inhibitors?

A
  • Brush border enzyme that breaks down starch and disaccharides to glucose
  • Inhibitors - delay absorption of glucose
21
Q

Examples of a-glucosidase inhibitors? What are they used for?
Side effects?

A
  • Acarbose, miglitol, voglibose
  • Used in 2TDM patients inadequately controlled

Side effects = GI upset

22
Q

Biguanide example?

When is it used?

A

Metformin!

* First line agent in T2DM EXCEPT in hepatic or renal impairment

23
Q

Mechanism of action of metformin?

Effects? (3)

A

reduces hepatic gluoconeogenesis [by stimulating AMP-activated protein kinase (AMPK)]

  • increases glucose uptake and utilization by skeletal muscle (increases insulin signalling)
  • reduces carbohydrate absorption
  • increases fatty acid oxidation
24
Q

Advantages of metformin? (5)

Disadvantages? (2)

A

Advantages

  • decreased microvascular complications
  • can be administered orally
  • prevents hyperglycaemia but does NOT cause hypoglycaemia
  • causes weight loss
  • can be combined with other agents (e.g. insulin, SU, TZD)

disadvantages

  • GI upset
  • LACTIC ACIDOSIS (rare) - in patients with hepatic or renal disease or excessive alcohol consumption
25
Q

Explain mechanism of action of TZDs? (3)

A
  • Enhance the action of insulin at target tissues, but do not directly affect insulin secretion – i.e. reduce insulin resistance
  • Act as exogenous agonists of the nuclear receptor PPARy which associates with RXR
  • Activated PPAR-RXR complex acts as a transcription factor that binds to DNA to promote the expression of genes involved in insulin signalling and lipid metabolism
26
Q

Desirable effects of TZD’s? (4)

A
  • promote fatty acid uptake and storage in adipocytes (rather than liver)
  • reduce hepatic glucose output
  • enhance peripheral glucose uptake
  • do not cause hypoglycaemia
27
Q

Adverse effects of TZD’s? (4)
Other name for TZDs?
Contraindications?

A
  • weight gain
  • fluid retention – TZDs promote Na+ reabsorption by the kidney
  • several members of the class (e.g. ciglitazone, troglitazone) cause serious hepatotoxicity – only pioglitazone (which does not cause liver dysfunction) is now used
  • increased incidence of bone fractures

Other name = glitazones
* Contraindicated in heart failure!!

28
Q

Are sodium-glucose cotransportr 2 (SGLT2) inhibitors insulin dependent?
Mechanism of action?

A

No, insulin independent
* selectively block the reabsorption of glucose by SGLT2 in the proximal tubule of the kidney nephron to deliberately cause glucosuria

29
Q

How to SGLT2 inhibitors cause weight loss?

Examples of SGLT2 inhibitors?

A

Calorific loss (i.e. glucose voided) and water accompanying glucose (i.e. osmotic diuresis) contributes to weight loss

e.g. dapagliflozin, canagliflozin, empagliflozin